Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer.


Updates from The Motley Fool

Latest updates on Merrimack Pharmaceuticals from Fool.com.


Stock Performance

MACK vs. S&P 500 | 2 Year Performance
View Interactive MACK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merrimack Pharmaceuticals.
Current Price: $6.26
Prev Close: $6.20
Open: $6.24
Bid: $6.25
Ask: $6.29
Day's Range: $6.11 - $6.36
52wk Range: $4.39 - $10.85
Volume: 3,569,846
Avg Vol 2,709,714
Market Cap: $723.49M
P/E (ttm): -4.03
EPS (ttm): -$1.54
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Merrimack Pharmaceuticals.
CAPS Rating 4 out of 5
 
93 Outperform
9 Underperform
CAPS All Stars
 
16 Outperform
4 Underperform

How do you think Merrimack Pharmaceuticals will perform against the market?



You pick for Merrimack Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Robert J. Mulroy, CEO

66% Approve

Based on 12 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merrimack Pharmaceuticals.

Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers